Case Control Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 14, 2023; 29(22): 3482-3496
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3482
Table 1 Clinical characteristics of individuals in test cohort and validation cohort, and total participants, n (%)
CharacteristicTest cohort (n = 91)
Validation cohort (n = 212)
Total participants (n = 303)
HD (n = 22)
GC (n = 69)
HD (n = 41)
GC (n = 171)
HD (n = 63)
GC (n = 240)
Gender
    Male12 (54.55)51 (73.91)31 (75.61)136 (79.53)43 (68.25)187 (77.92)
    Female10 (45.45)18 (26.09)10 (24.39)35 (20.47)20 (31.75)53 (22.08)
Age (yr), median (range)54 (32-77)66 (35-84)53 (24-81)64 (34-94)53 (24-81)64 (34-94)
T stage///
    T169 (100.00)108 (63.16)177 (73.75)
    T207 (4.09)7 (2.92)
    T3037 (21.64)37 (15.42)
    T4019 (11.11)19 (7.91)
N stage///
    N069 (100.00)124 (72.51)193 (80.42)
    N1011 (6.43)11 (4.58)
    N2014 (8.19)14 (5.83)
    N3022 (12.87)22 (9.17)
M stage///
    M069 (100.00)162 (94.74)231 (96.25)
    M109 (5.26)9 (3.75)
Clinical stage///
    I69 (100.00)111 (64.91)180 (75.00)
    II016 (9.36)16 (6.67)
    III035 (20.47)35 (14.58)
    IV09 (5.26)9 (3.75)